Additionally, the PDL of T2D mice contained more cells expressing the proinflammatory cytokine IL-6 compared with the PDL of control mice, and Scl-Ab treatment decreased the abundance of IL-6-expressing cells to levels similar to control mice (Figure 7, M–P). Here, IL6 is linked to type 2 diabetes mellitus.